Venus Remedies Limited (BOM:526953)
668.75
+18.15 (2.79%)
At close: Mar 4, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 9.37 billion as of March 5, 2026. Its market cap has increased by 118.07% in one year.
Market Cap
9.37B
Enterprise Value
7.16B
Revenue
7.03B
Ranking
n/a
PE Ratio
12.28
Stock Price
668.75
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 9.37B, an increase of 3,759.28%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 9.37B | -8.59% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lincoln Pharmaceuticals | 12.77B |
| TTK Healthcare | 12.64B |
| Syncom Formulations (India) | 11.55B |
| Fermenta Biotech | 9.39B |
| Wanbury | 9.29B |
| Bharat Parenterals | 7.87B |
| Anuh Pharma | 7.77B |
| Fredun Pharmaceuticals | 7.36B |